Staff Scientist, BME, Duke University
Technologies like optogenetics and chemogenetics, which artificially control neurons, are typically delivered to neurons via viral vectors. However, their application has been limited to rodents, creating a gap in primate research and reducing clinical relevance. I suggest this is due to a lack of primate-optimized viral vectors. My presentation will cover the evidence for this, my current and future work in adapting these technologies for primates, and their potential clinical impacts.